Implenia (SWX:IMPN) is back in focus after confirming its full year 2026 earnings guidance, targeting EBIT of around CHF 150 million before CHF 10 million to CHF 20 million of growth investments.
The guidance confirmation comes after Implenia reported half year 2026 earnings on 18 August. The stock has responded with a 16.45% 90 day share price return and a 9.70% 30 day move, even though the year to date share price return is still down 11.27%, while the 5 year total shareholder return is 253.91%. This hints that long term holders have seen strong compounding, even as shorter term momentum has only recently picked up.
Scan other construction and infrastructure stocks that share Implenia's mix of earnings guidance and recent price momentum with a curated list of 274 high quality undervalued stocks.
After a sharp rebound but with Implenia still trading below some valuation estimates, the real question for you is whether recent gains already reflect the confirmed guidance, or if a meaningful part of the potential upside is still ahead.
With Implenia last closing at CHF70.10 against a narrative fair value of CHF86, the current share price sits below what the most followed narrative considers reasonable given its growth and earnings profile.
Increasing specialization in complex, higher-margin segments (such as tunneling, healthcare infrastructure, data centers, and property management) is enabling Implenia to move away from low-margin "Me Too" contracts, supporting both gradual margin expansion and earnings quality improvement in coming years. Early adoption of digitalization, process automation, and AI in both project management and execution is expected to drive future cost efficiencies, improve project selection and delivery, and structurally lift net margins over time.
Read the complete narrative. Read the complete narrative.
Want to see what sits behind that higher fair value for Implenia? The narrative leans on steadier revenue growth, firmer margins, and a future earnings multiple you might not expect for a construction stock. The exact mix of growth, profitability and required return is all laid out there, but the numbers only make sense once you see how they fit together.
Result: Fair Value of CHF86 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the narrative around Implenia still hinges on progress with free cash flow and leverage, as ongoing cash outflows and a modest equity base could easily unsettle that story.
Find out about the key risks to this Implenia narrative.
With sentiment on Implenia pulled between those risks and rewards, it makes sense to move fast and test the numbers for yourself. To weigh both sides clearly and decide where you stand, start with the 4 key rewards and 1 important warning sign.
If Implenia has sharpened your focus, do not stop here. Broaden your watchlist with other clear ideas that match different risk, income and balance sheet preferences.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com